Cosmos Study November 13, 2025 Dual-Team Study Team A:Kersten Bartelt, RNDan GreerEmily Higgs Team B:Louis Kazaglis, MDTed Stamp Key Findings Among patients with polycystic ovary syndrome (PCOS), the median one-year weight change was an 11.5% loss for those treated with a GLP-1, compared to a 1.9% loss among those treated with metformin
The peptide upregulates expression of epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor among others
B activation and suppresses the release of TNF-?, IL-1?, and IL-6, decreasing chronic low-grade inflammation linked to aging and tissue degeneration 4
Follow-ups remain available to ensure results are protected
At the entrance to the active site, KA is stabilized by interactions with Phe197, Pro201, Asn205, and Arg209 (Fig
Tanaka, S., Avigad, G., Brodsky, B